Hormonal, Immunological, and Familial Risk Factors Influencing Pregnancy Outcome after Intrauterine Insemination in Tikrit, Iraq
Downloads
Background: Infertility affects roughly 15% of couples globally with female-factor infertility contributing to nearly 40% of the cases. Intrauterine insemination (IUI) is the first line assisted reproductive technology (ART). The outcome depends largely on the relationship between the hormonal environment and immunological tolerance at the endometrial interface. Objectives: The purpose of this study is to assess certain biochemical hormones and immunological markers in women receiving intrauterine insemination (IVI) in Tikrit, including follicle stimulating hormone (TSH), prolactin, estrogen, testosterone, and ANA. We will also look for correlations with pregnancy rate, BMI, and family genetic history. Methods: One hundred women who were having intrauterine inseminations (IUIs) at the Reproductive Medicine Unit of Tikrit Teaching Hospital were the subjects of a prospective case-control study that ran from September 2023 to April 2024. A total of 47 pregnant women and 53 non-pregnant women made up the study's participants. During the second and third days of menstruation, blood samples were taken. The chemiluminescent immunoassay and enzyme-linked immunosorbent assay were used to conduct the hormonal tests. We used a multiplex bead-based immunoassay to profile cytokines. Using a standardized questionnaire, we were able to determine body mass index and document family history. In addition, the discriminative performance of important biomarkers was assessed using receiver operating characteristic (ROC) analysis. Results: While the pregnant group showed noticeably increased levels of AMH, E2, IL-10, IL-4, and CD4+/CD8+ ratio, the non-pregnant group showed considerably enhanced levels of FSH, prolactin, TSH, testosterone, IL-6, TNF-α, NK cell activity, anti-sperm IgG, ANA titers, antiphospholipid antibodies, and CRP (p<0.05). BMI was positively correlated with pro-inflammatory cytokines and significantly negatively correlated with pregnancy rate and AMH levels (r=−0.48, p<0.001 and r=−0.52, p<0.001, respectively). Pregnancy probabilities were considerably lowered (p<0.05) in cases where there was a positive family history of infertility, polycystic ovary syndrome, autoimmune disease, or thyroid condition. An AUC of 0.99 was achieved for the discriminative performance of a combined biomarker model for pregnancy outcome, which included AMH, BMI, IL-6, IL-10, and FSH. Conclusions: The hormonal and immunological profile is a robust predictor of IUI outcome. Elevated BMI and positive family genetic history independently reduce pregnancy rates, underscoring the need for personalized pre-IUI assessment integrating metabolic, immunological, and genomic risk stratification.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
